Serum interleukin-18 levels are elevated in schizophrenia

Psychiatry Research

Volumn 96, Issue 1, 2000, Pages 75-80

  Tanaka, Kenji F ^a   Shintani, Futoshi ^a   Fujii, Yasuo ^b   Yagi, Gohei ^a   Asai, Masahiro ^a  

^a KEIO UNIVERSITY   (Japan)

^b Yamanashi Prefectural Kita Hospital   (Japan)

Author keywords

Cytokines; Immune activation; Immunology; Interleukin 18; Schizophrenia

Indexed keywords

INTERLEUKIN 18;

ADULT; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADULT; CASE-CONTROL STUDIES; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNITY, CELLULAR; INTERLEUKIN-18; MALE; MIDDLE AGED; SCHIZOPHRENIA; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 0034715155     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1781(00)00196-7     Document Type: Article

References (29)

1. American Psychiatric Association, 1994. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. American Psychiatric Press, Washington, DC.
2. Baker I., Masserano J., Wyatt R.J. Serum cytokine concentrations in patients with schizophrenia. Schizophrenia Research. 20:1996;199-203.
3. Ganguli R., Rabin B.S. Increased serum interleukin 2 receptor concentration in schizophrenic and brain-damaged subjects. Archives of General Psychiatry. 46:1989;292.
4. Inagaki, A., Inada, T., Fujii, Y., Yagi, G., Yoshio, T., Nakamura, H.,Yamauchi, T. 1999. Dose Equivalence of Psychotropic Drugs. Seiwa Shoten Publisher, Tokyo.
5. Katila H., Appelberg B., Hurme M., Rimon R. Plasma levels of interleukin-1 beta and interleukin-6 in schizophrenia, other psychoses, and affective disorders. Schizophrenia Research. 12:1994;29-34.
6. Kawashima M., Yamamura M., Morita Y., Makino H., Tanimoto T., Kurimoto M. Elevated levels of IFN-gamma-inducing factor (IGIF) in synovial fluid of patients with rheumatoid arthritis. Arthritis and Rheumatism. 39:1996;598.
7. Kawashima M., Yamaura M., Morita Y., Tanimoto T., Kurimoto M., Makino H. Highly elevated levels of serum interleukin-18 in adult onset Still's disease. Arthritis and Rheumatism. 41:1998;S39.
8. Kohno K., Kurimoto M. Interleukin 18, a cytokine which resembles IL-1 structurally and IL-12 functionally but exerts its effect independently of both. Clinical Immunology and Immunopathology. 86:1998;11-15.
9. Leykin I., Mayer R., Shinitzky M. Short- and long-term immunosuppressive effects of clozapine and haloperidol. Immunopharmacology. 37:1997;75-86.
10. Maes M., Bosmans E., Calabrese J., Smith R., Meltzer H.Y. Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers. Journal of Psychiatric Research. 29:1995;141-152.
11. Maes M., Bosmans E., Ranjan R., Vandoolaeghe E., Meltzer H.Y., De Ley M., Berghmans R., Stans G., Desnyder R. Lower plasma CC16, a natural anti-inflammatory protein, and increased plasma interleukin-1 receptor antagonist in schizophrenia: effects of antipsychotic drugs. Schizophrenia Research. 21:1996;39-50.
12. McFarlin D.E., McFarland H.F. Multiple sclerosis. New England Journal of Medicine. 307:1982;1246-1251.
13. Moises H.W., Schindler L., Leroux M., Kirchner H. Decreased production of interferon alpha and interferon gamma in leucocyte cultures of schizophrenic patients. Acta Psychiatrica Scandinavica. 72:1985;45-50.
14. Müller N., Empl M., Riedel M., Schwarz M., Ackenheil M. Neuroleptic treatment increases soluble IL-2 receptors and decreases soluble IL-6 receptors in schizophrenia. European Archives of Psychiatry and Clinical Neuroscience. 247:1997;308-313.
15. Okamura H., Tsutsi H., Komatsu T., Yutsudo M., Hakura A., Tanimoto T., Torigoe K., Okura T., Nukada Y., Hattori K. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature. 378:1995;88-91.
16. Pacifici R. Aging and cytokine production. Calcified Tissue International. 65:1999;345-351.
17. Pollmächer T., Hinze-Selch D., Mullington J. Effects of clozapine on plasma cytokine and soluble cytokine receptor levels. Journal of Clinical Psychopharmacology. 16:1996;403-409.
18. Pollmächer T., Hinze-Selch D., Mullington J., Fenzel T., Holsboer F. Smoking affects plasma-soluble interleukin-2 receptor levels in patients with schizophrenia. Archives of General Psychiatry. 54:1997;89-90.
19. Rapaport M.H., McAllister C.G., Pickar D., Nelson D.L., Paul S.M. Elevated levels of soluble interleukin 2 receptors in schizophrenia. Archives of General Psychiatry. 46:1989;291-292.
20. Shintani F., Kanba S., Maruo N., Nakaki T., Nibuya M., Suzuki E., Kinoshita N., Yagi G. Serum interleukin-6 in schizophrenic patients. Life Sciences. 49:1991;661-664.
21. Smith R.S. A comprehensive macrophage-T-lymphocyte theory of schizophrenia. Medical Hypotheses. 39:1992;248-257.
22. Smith R.S., Maes M. The macrophage-T-lymphocyte theory of schizophrenia: additional evidence. Medical Hypotheses. 45:1995;135-141.
23. Stevens J.R. Schizophrenia and multiple sclerosis. Schizophrenia Bulletin. 14:1988;231-241.
24. Tollerud D.J., Weiss S.T., Leung D.Y. Elevated soluble interleukin-2 receptors in young healthy cigarette smokers: lack of association with atopy or airways hyperresponsiveness. Intenational Archives of Allergy and Immunology. 97:1992;25-30.
25. Tsutsui H., Nakanishi K., Matsui K., Higashino K., Okamura H., Miyazawa Y., Kaneda K. IFN-gamma-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones. Journal of Immunology. 157:1996;3967-3973.
26. Ushio S., Namba M., Okura T., Hattori K., Nukada Y., Akita K., Tanabe F., Konishi K., Micallef M., Fujii M., Torigoe K., Tanimoto T., Fukuda S., Ikeda M., Okamura H., Kurimoto M. Cloning of the cDNA for human IFN-gamma-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein. Journal of Immunology. 156:1996;4274-4279.
27. Villemain F., Chatenoud L., Guillibert E., Pelicier Y., Bach J.F. Decreased production of interleukin-2 in schizophrenia. Annals of the New York Academy of Sciences. 496:1987;669-675.
28. Wildbaum G., Youssef S., Grabie N., Karin N. Neutralizing antibodies to IFN-gamma-inducing factor prevent experimental autoimmune encephalomyelitis. Journal of Immunology. 161:1998;6368-6374.
29. Wilke I., Arolt V., Rothermundt M., Weitzsch C., Hornberg M., Kirchner H. Investigations of cytokine production in whole blood cultures of paranoid and residual schizophrenic patients. European Archives of Psychiatry and Clinical Neuroscience. 246:1996;279-284.